Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined array key "thumbnail" in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 25
StackHealth / FDA Removes Suicide Warnings from GLP‑1 Drugs

FDA moves to remove suicide warnings from GLP-1 weight loss drugs

medicalxpress - Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication labels.

AI Summary: In a surprising twist, the FDA has decided that the long‐rumored risk of suicidal ideation on popular GLP‑1 weight‐loss drugs may have been overblown. Regulators have now asked drugmakers – including Lilly and Novo Nordisk – to scrub these warnings from product labels, a move that is sure to spark both relief and raised eyebrows among critics.

#obesity #healthcare #pharmaceuticals #elililly #novonordisk #weightloss #publichealth #governmentpolicy #fda

Physician-Journalist Shines Light on Measles Upsurge and New GLP-1 Study

4 months / kffhealthnews

What Merck’s Chief Medical Officer Thinks of Lilly’s Approach to GLP-1s

4 months / medcitynews / Arundhati Parmar

Long-term GLP-1 use trims medical cost growth: Aon

4 months / beckershospitalreview / Elizabeth Casolo

GLP-1s tied to improved survival in colorectal cancer

4 months / beckershospitalreview / Paige Twenter

FDA moves to remove suicide warnings from GLP-1 weight loss drugs

4 months / medicalxpress

Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial

4 months / nature / Atul Malhotra

FDA moves to strike suicide risk warnings from 3 GLP-1s

4 months / beckershospitalreview / Ella Jeffries

FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels

4 months / endpoints / Zachary Brennan

Back to Top / Thursday, January 15, 2026, 1:23 pm / permalink 17924 / 8 stories in 4 months /


Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61


Related Stories


Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Trump Administration Secures Lower Obesity Drug Prices / 6 months

GLP‑1 drugs associated with lower addiction risk in large study / 2 months

Lilly fights classification ruling as stockpile and compounding lawsuits swirl / 3 months

Compounding Pharmacy Sues Lilly and Novo Nordisk / 4 months

Novo Nordisk Seeks FDA Nod for Higher‐Dose Wegovy / 6 months

Lilly’s Zepbound bests Novo’s CagriSema in head‑to‑head obesity trial / 3 months

Novo Nordisk oral GLP‑1 pill clears FDA for obesity treatment / 5 months

StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try None, Rural Health, Cancer Screening, Venture Capital and look for the RSS link.


↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.